Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$415M |
| 2 |
Eli Lilly
LLY
|
+$402M |
| 3 |
Goldman Sachs
GS
|
+$384M |
| 4 |
McDonald's
MCD
|
+$379M |
| 5 |
Tesla
TSLA
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.98B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 3 |
AT&T
T
|
+$460M |
| 4 |
Synchrony
SYF
|
+$398M |
| 5 |
Honeywell
HON
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.97% |
| 2 | Financials | 4.82% |
| 3 | Healthcare | 4.18% |
| 4 | Industrials | 3.64% |
| 5 | Consumer Discretionary | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ULTI
3076
PUT
DELISTED
Ultimate Software Group Inc
ULTI
| $4.26M | ﹤0.01% |
12,900
-1,300
| -9% | -$399K |
|
3077
Imperial Oil
IMO
$64.5B
| $4.26M | ﹤0.01% |
155,620
+3,415
| +2% | +$93K |
|
3078
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46B
| $4.25M | ﹤0.01% |
+81,576
| New | +$4.19M |
|
|
THS
3079
CALL
DELISTED
Treehouse Foods
THS
| $4.25M | ﹤0.01% |
65,800
+39,800
| +153% | +$2.35M |
|
3080
iShares US Aerospace & Defense ETF
ITA
$15.1B
| $4.24M | ﹤0.01% |
+42,526
| New | +$4.16M |
|
3081
Unilever
UL
$134B
| $4.24M | ﹤0.01% |
65,259
-96,761
| -60% | -$5.89M |
|
|
CEO
3082
CALL
DELISTED
CNOOC Limited
CEO
| $4.24M | ﹤0.01% |
22,800
-200
| -0.9% | -$33.9K |
|
3083
Innoviva
INVA
$1.53B
| $4.23M | ﹤0.01% |
301,712
+159,016
| +111% | +$2.58M |
|
3084
Vera Bradley
VRA
$93M
| $4.23M | ﹤0.01% |
319,543
+104,149
| +48% | +$1.06M |
|
|
NVO
3085
CALL
Novo Nordisk
NVO
$201B
| $4.23M | ﹤0.01% |
161,800
-161,600
| -50% | -$3.97M |
|
3086
CALL
YPF Sociedad Anonima ADS
YPF
$19.6B
| $4.23M | ﹤0.01% |
302,100
-130,600
| -30% | -$1.91M |
|
|
FRC
3087
CALL
DELISTED
First Republic Bank
FRC
| $4.23M | ﹤0.01% |
42,100
+4,400
| +12% | +$433K |
|
3088
CALL
Coherent
COHR
$63.7B
| $4.23M | ﹤0.01% |
113,500
+67,900
| +149% | +$2.51M |
|
|
ZAYO
3089
CALL
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $4.23M | ﹤0.01% |
148,700
-227,700
| -60% | -$6.04M |
|
3090
CALL
Ionis Pharmaceuticals
IONS
$9.51B
| $4.21M | ﹤0.01% |
51,900
-13,700
| -21% | -$884K |
|
3091
PUT
H&R Block
HRB
$6.83B
| $4.2M | ﹤0.01% |
175,500
-126,100
| -42% | -$3.1M |
|
3092
CALL
Chemours
CC
$2.39B
| $4.19M | ﹤0.01% |
112,800
+4,700
| +4% | +$171K |
|
3093
Varonis Systems
VRNS
$5.17B
| $4.19M | ﹤0.01% |
210,639
-80,538
| -28% | -$1.53M |
|
3094
PUT
Evergy
EVRG
$19.4B
| $4.18M | ﹤0.01% |
+72,000
| New | +$4.1M |
|
3095
PUT
Labcorp
LH
$25.8B
| $4.18M | ﹤0.01% |
31,777
+6,518
| +26% | +$803K |
|
3096
CALL
Delek US
DK
$4.01B
| $4.17M | ﹤0.01% |
114,500
+29,600
| +35% | +$1.01M |
|
3097
MACOM Technology Solutions
MTSI
$24.2B
| $4.17M | ﹤0.01% |
249,324
-130,988
| -34% | -$2.28M |
|
3098
MPLX
MPLX
$60.3B
| $4.16M | ﹤0.01% |
+126,348
| New | +$4.24M |
|
3099
CALL
Arthur J. Gallagher & Co
AJG
$64.4B
| $4.16M | ﹤0.01% |
53,200
+41,800
| +367% | +$3.22M |
|
3100
Quad
QUAD
$513M
| $4.15M | ﹤0.01% |
349,064
-146,983
| -30% | -$1.97M |
|
Similar funds
Ken Griffin's Q1 2019 Portfolio in Review
As of Q1 2019, Ken Griffin held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $13B in Q1 2019, closing 1,251 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6% of assets, up from 4.8% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ken Griffin opened a new position in Elanco Animal Health worth $251M.
- Ken Griffin's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
- Ken Griffin added most to Walt Disney in Q1 2019, an estimated $415M increase.
- Ken Griffin's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
- Ken Griffin fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
- Ken Griffin's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
- Ken Griffin opened 1,429 new positions and closed 1,251 in Q1 2019.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $201B.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.